Literature DB >> 15266144

Orbital involvement in juvenile nasopharyngeal angiofibroma: prevalence and treatment.

Antonio A V Cruz1, João M C Atique, Francisco V Melo-Filho, Jorge Elias.   

Abstract

PURPOSE: To assess the prevalence of orbital invasion by juvenile nasoangiofibroma and to discuss its surgical treatment.
METHODS: A retrospective review of the medical records and tomographic scans of a case series of 19 patients with juvenile nasoangiofibroma was performed. All scans were reviewed by a radiologist and an orbital surgeon. The presence of the tumor was assessed in the pterygopalatine fossa, nasal cavity, nasopharynx, paranasal sinuses, inferior orbital fissure, orbit, and middle cranial fossa.
RESULTS: The most common structures invaded were pterygopalatine fossa (100%), nasal cavity (94.7%), sphenoid sinus (84.2%), and nasopharynx (73.7%). The orbit was invaded in 6 (31.6%) patients. In 5 of these patients, the tumor extended in the orbit through the inferior orbital fissure. Four patients with orbital invasion were successfully operated with the Le Fort I approach.
CONCLUSIONS: Orbital involvement is relatively common in the setting of juvenile nasoangiofibroma extension. The main route of orbital invasion is the inferior orbital fissure. The Le Fort I osteotomy is an adequate approach for managing juvenile nasoangiofibroma when it invades the orbit.

Entities:  

Mesh:

Year:  2004        PMID: 15266144     DOI: 10.1097/01.iop.0000132163.00869.44

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  2 in total

1.  Extensive nasopharyngeal angiofibromas: the maxillary swing approach.

Authors:  Neeraj Narayan Mathur; Ashish Vashishth
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-04       Impact factor: 2.503

2.  Co-existing of sinonasal inverted papilloma and angiofibroma: case report and review of the literature.

Authors:  Behzad Shahrjerdi; Ali Angoyaroko; Baharudin Abdullah
Journal:  Acta Inform Med       Date:  2012-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.